On the other hand, still concerning breast cancer, certain variations (in particular the rs438421 SNP) would be protective by improving the activity of the IL-12R receptor, thus promoting the production of IFN-γ especially in cytotoxic T cells (van de Vosse et al., 2013; Núñez-Marrero 2020). This evidence concerns the gene IFNG and breast carcinoma.